Prof. Hafezi flew to South Africa to attend OSSA 2024 and give presentations that showcased the latest innovations in corneal cross-linking and biomechanics assessments.
Dr. Dion Paridaens delivered key lectures at the STO Annual Meeting, discussing advancements in functional and aesthetic eyelid surgery.
On February 23, 2024, Nikki Hafezi, MAS IP ETHZ, delivered a presentation titled “AI – To Detect & Diagnose Keratoconus” at the MEDICRES.AI 2024
online conference. This well-attended event, hosted by the Medical and Clinical Research Support Society, featured a spectrum of experts from various medical disciplines, with a dedicated focus on leveraging artificial intelligence (AI) to bolster global health.
The ELZA Institute’s surgeons and researchers were in Frankfurt this month to present our latest research and results at Winter ESCRS 2024.
A recent publication in TVST by ELZA’s M. Enes Aydemir et al. presents an insightful study on how performing sequential corneal cross-linking with riboflavin/UV and rose bengal/green light protocols can increase corneal digestion resistance greater than each protocol on its own.
Expertscape continuously monitor the research output of all peer-reviewed publication on PubMed and rank the top researchers across all of Medicine. Currently, ELZA has #1, #2 and #5 for corneal cross-linking.
Let’s delve into the insightful presentations given by two of ELZA’s finest surgeons during ELZA at Swiss Ophthalmological Society (SSO)’s Swiss Eye Week 2024, highlighting the contributions of ELZA’s Medical Director, Prof. Farhad Hafezi and consultant glaucoma surgeon, Prof. Kaweh Mansouri on Wednesday, January 17th, 2024. The conference was held to educate Switzerland’s up and coming ophthalmology residents, and is a highly anticipated meeting each year. This year, the meeting was held at that Belvédère Strandhotel, Spiez.
Last week, Prof Hafezi gave a keynote lecture at the International Keratoconus & Corneal Crosslinking Summit 2024, held in Shanghai, China, on the topic of “The Future of Keratoconus Care Without Corneal Transplantation”
The Ophthalmologist’s “CXL: What’s New in 2023?” article explores advancements in corneal collagen crosslinking for treating keratoconus. ELZA’s Farhad Hafezi discusses how CXL has advanced to the current state of the art, and highlights new breakthroughs like sub400 and PACE.
New study reveals how accelerated PACK-CXL with riboflavin/UV-A or rose bengal/green light can be effective treatments for bacterial keratitis.
